ACOT1 and gastric cancer: Kaplan–Meier survival analysis revealed that patients with high ACOT1 expression exhibited poorer overall survival compared to those with low expression, underscoring ACOT1's potential clinical relevance as a prognostic biomarker and therapeutic target in GC (Fig. 5D).